Dr. Randy Fink Joins NewLIFE Fertility, Expanding Patient-Centered Reproductive Care
March 2025 – NewLIFE Fertility is pleased to welcome Dr. Randy Fink, MD, to our team as a fertility specialist. With extensive experience in reproductive endocrinology, IVF, and fertility procedures, Dr. Fink brings advanced expertise in patient-centered fertility care. He is now accepting new patients at our Gulf Coast locations.
A Leader in Fertility and Women’s Health
Throughout his career, Dr. Fink has been recognized as a leader in gynecology and fertility care, with a reputation for innovation and excellence. A board-certified specialist in obstetrics and gynecology, he has managed thousands of fertility cycles and has been a trusted advocate for women’s health for over two decades. His expertise extends to hormones, sexual wellness, and reproductive treatments, ensuring patients receive comprehensive, individualized care.
Dr. Fink completed his undergraduate studies at The American University and earned his medical degree from the Medical College of Virginia. He then completed his obstetrics and gynecology training at the esteemed Brown University/Women & Infants Hospital of Rhode Island.
“Dr. Fink’s wealth of experience and dedication to patient-centered fertility care make him a valuable addition to our team,” said Dr. Barry Ripps, M.D., FACOG, at NewLIFE Fertility. “His holistic approach and deep compassion for patients will enhance our ability to provide exceptional fertility care to individuals and families across the Gulf Coast.”
Outside of his professional life, Dr. Fink is a devoted father to three children and a passionate advocate for patient education. His approach to care will help every patient feel heard, supported, and empowered throughout their fertility journey.
About NewLIFE Fertility
NewLIFE Fertility is a leading reproductive health center serving the Gulf Coast region, including Mobile and Dothan, Alabama; and Tallahassee, Panama City, and Pensacola, Florida. Our dedicated team of board-certified fertility specialists offers a comprehensive range of services, from infertility care to advanced reproductive technology. We are committed to providing personalized, compassionate care to help individuals and couples achieve their dream of building a family. For more information or to schedule an appointment, visit fertilityleaders.com.
About First Fertility
First Fertility offers comprehensive and customized care for patients hoping to grow their families. We not only invest in reproductive endocrinology practices nationwide, but we also build strategic partnerships that put the focus on what matters most: taking care of patients. First Fertility has 49 physicians and 54 locations in North America, serving patients in 15 states, including Alabama, California, Connecticut, Florida, Illinois, Louisiana, Maine, Massachusetts, Mississippi, Missouri, New Hampshire, New York, Oklahoma, Rhode Island, and Texas. Learn more at firstfertility.com.
Media Inquiries: If you would like more information, please contact Jennifer Beresch at [email protected].
EMBCOL American College of Embryology announces Dr. Brijinder S. Minhas, PhD, HCLD, ELD, ALD, CC, MBA - Embryologist of the Month July 2021
Dr. Brijinder S. Minhas serves as the Scientific Director and Chief Operating Officer at New Leaders In Fertility & Endocrinology in Pensacola, Florida since its inception in 2000 to present. Previously he served as Regional Scientific Director and Vice President of Operations for IntegraMed America. Dr. Minhas earned his Doctorate at Texas A&M University in 1984 under the tutelage of Professor Duane Kraemer, a pioneer in the field of embryo transfer. Dr. Minhas’ early investigations were in the area of transgenic animal creation. He started his career in human IVF in 1986 in Johnson City Tennessee alongside Professor Melvin Dodson at the James H. Quillen College of Medicine at East Tennessee State University.
Dr. Minhas rose to the rank of Associate Professor in the Department of Obstetrics and Gynecology prior to moving to the University of Tennessee College of Medicine in Memphis, as the Chief of Reproductive Biology. He has trained many graduate students, medical students, residents and REI fellows in his teaching career. He has several major contributions to the literature, in particular highlighting the integral role of Platelet Activating Factor in the regulation of mammalian reproduction.
Dr. Minhas has been a very early adopter of technology and at the very first State of the ART ABB conference in St. Louis he presented his experience with clinical data on over 500 patients with ICSI. Having performed pronuclear DNA injections in many species, injecting sperm in human eggs came quite easily to him. This early ICSI data was generated by him when he served as Scientific Director at the Center for Human Reproduction in Chicago. Dr. Minhas continues to provide scientific, clinical and business consultancy services to many ART programs through his company, Global Infertility Solutions, LLC. He has lectured extensively nationally and internationally on many different aspects of mammalian reproduction and ART. He is a member of many professional organizations. View original publication here.
